Sweden
· Delayed Price · Currency is SEK Medimi AB Statistics
Total Valuation
Medimi AB has a market cap or net worth of SEK 7.76 million. The enterprise value is 6.35 million.
| Market Cap | 7.76M |
| Enterprise Value | 6.35M |
Important Dates
The next estimated earnings date is Monday, November 4, 2024.
| Earnings Date | Nov 4, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Medimi AB has 1.08 billion shares outstanding. The number of shares has increased by 54.75% in one year.
| Shares Outstanding | 1.08B |
| Shares Change (YoY) | +54.75% |
| Shares Change (QoQ) | -3.45% |
| Owned by Insiders (%) | 5.05% |
| Owned by Institutions (%) | n/a |
| Float | 1.02B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.98 |
| PB Ratio | 1.00 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.47 |
| EV / Sales | 1.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.45 |
Financial Position
The company has a current ratio of 3.40, with a Debt / Equity ratio of 38.70.
| Current Ratio | 3.40 |
| Quick Ratio | 2.38 |
| Debt / Equity | 38.70 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.21 |
| Interest Coverage | -38.69 |
Financial Efficiency
Return on equity (ROE) is -152.36% and return on invested capital (ROIC) is -79.82%.
| Return on Equity (ROE) | -152.36% |
| Return on Assets (ROA) | -61.78% |
| Return on Capital (ROIC) | -79.82% |
| Revenue Per Employee | 695,401 |
| Profits Per Employee | -2.27M |
| Employee Count | 6 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 0.91 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.64% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -83.64% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 25.12 |
| Average Volume (20 Days) | 5,454,326 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medimi AB had revenue of SEK 4.17 million and -13.64 million in losses. Loss per share was -0.01.
| Revenue | 4.17M |
| Gross Profit | 1.70M |
| Operating Income | -13.35M |
| Pretax Income | -13.64M |
| Net Income | -13.64M |
| EBITDA | -12.11M |
| EBIT | -13.35M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 4.41 million in cash and 3.00 million in debt, giving a net cash position of 1.41 million or 0.00 per share.
| Cash & Cash Equivalents | 4.41M |
| Total Debt | 3.00M |
| Net Cash | 1.41M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 7.75M |
| Book Value Per Share | 0.01 |
| Working Capital | 7.53M |
Cash Flow
In the last 12 months, operating cash flow was -13.39 million and capital expenditures -864,507, giving a free cash flow of -14.25 million.
| Operating Cash Flow | -13.39M |
| Capital Expenditures | -864,507 |
| Free Cash Flow | -14.25M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | 40.75% |
| Operating Margin | -319.93% |
| Pretax Margin | -326.89% |
| Profit Margin | n/a |
| EBITDA Margin | -290.22% |
| EBIT Margin | n/a |
| FCF Margin | -341.63% |
Dividends & Yields
Medimi AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -54.75% |
| Shareholder Yield | -54.75% |
| Earnings Yield | -198.26% |
| FCF Yield | -183.59% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |